Medirom Healthcare Stock Forecast - Jensen Alpha

MRM Stock  USD 2.64  0.06  2.22%   
Medirom Stock Forecast is based on your current time horizon. Although Medirom Healthcare's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Medirom Healthcare's systematic risk associated with finding meaningful patterns of Medirom Healthcare fundamentals over time.
  
As of the 17th of November 2024, Receivables Turnover is likely to grow to 16.05, while Inventory Turnover is likely to drop 35.69. . As of the 17th of November 2024, Common Stock Shares Outstanding is likely to grow to about 5.4 M, though Net Loss is likely to grow to (847.1 M).
Medirom Healthcare Technologies has current Jensen Alpha of 0.
Check Medirom Healthcare VolatilityBacktest Medirom HealthcareInformation Ratio  

Medirom Healthcare Trading Date Momentum

On November 17 2024 Medirom Healthcare Technologies was traded for  2.64  at the closing time. Highest Medirom Healthcare's price during the trading hours was 2.72  and the lowest price during the day was  2.55 . There was no trading activity during the period 0.0. Lack of trading volume on the 17th of November 2024 did not cause price change. The trading delta at closing time to current price is 3.03% .
Compare Medirom Healthcare to competition

Other Forecasting Options for Medirom Healthcare

For every potential investor in Medirom, whether a beginner or expert, Medirom Healthcare's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Medirom Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Medirom. Basic forecasting techniques help filter out the noise by identifying Medirom Healthcare's price trends.

Medirom Healthcare Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medirom Healthcare stock to make a market-neutral strategy. Peer analysis of Medirom Healthcare could also be used in its relative valuation, which is a method of valuing Medirom Healthcare by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Medirom Healthcare Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Medirom Healthcare's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Medirom Healthcare's current price.

Medirom Healthcare Market Strength Events

Market strength indicators help investors to evaluate how Medirom Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Medirom Healthcare shares will generate the highest return on investment. By undertsting and applying Medirom Healthcare stock market strength indicators, traders can identify Medirom Healthcare Technologies entry and exit signals to maximize returns.

Medirom Healthcare Risk Indicators

The analysis of Medirom Healthcare's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Medirom Healthcare's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting medirom stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Medirom Healthcare to cross-verify your projections.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.582
Earnings Share
(0.15)
Revenue Per Share
1.4 K
Quarterly Revenue Growth
(0.06)
Return On Assets
(0.04)
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.